Overview

Antihypertensive Response to Losartan and Genetic Polymorphisms

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antihypertensive response of treatment with losartan with reference to genetic polymorphisms.
Phase:
N/A
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Antihypertensive Agents
Hydrochlorothiazide
Losartan